Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows Program and the International AIDS Vaccine Initiative

详细信息    查看全文

• 作者：Taryn Vian (4) (5)
  Sayaka Koseki (6)
  Frank G Feeley (4) (5)
  Jennifer Beard (4) (5)
  
• 刊名：BMC Health Services Research
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：13
• 期：1
• 全文大小：306 KB
• 参考文献：1. / About UNAIDS. [aids.org/en/aboutunaids/" class="a-plus-plus">http://www.unaids.org/en/aboutunaids/]
  2. Buse K, Walt G: Global public-private partnerships: part II–what are the health issues for global governance? / Bull World Health Organ 2000,78(5):699-09.
  3. Mayhew SH, Doherty J, Pitayarangsarit S: Developing health systems research capacities through north–south partnership: an evaluation of collaboration with South Africa and Thailand. / Health Res Policy Syst 2008, 6:8. CrossRef
  4. Casale M, Lane T, Sello L, Kuo C, Cluver L: Conducting health survey research in a deep rural South African community: challenges and adaptive strategies. / Health Res Policy Syst 2013, 11:14. CrossRef
  5. Corbin JH, Mittelmark MB, Lie GT: Scaling-up and rooting-down: a case study of North–south partnerships for health from Tanzania. / Global health action 2012, 5:18369. CrossRef
  6. Hartwig K, Humphries D, Matebeni Z: Building capacity for AIDS NGOs in southern africa: evaluation of a pilot initiative. / Health Promot Int 2008,23(3):251-59. CrossRef
  7. Humphries D, Gomez L, Hartwig K: Sustainability of NGO capacity building in southern Africa: successes and opportunities international. / Int J Health Plann Manage 2011, 26:e85-e101. CrossRef
  8. Manabe YC, Katabira E, Brough RL, Coutinho AG, Sewankambo N, Merry C: Developing independent investigators for clinical research relevant for Africa. / Health Res Policy Syst 2011, 9:44. CrossRef
  9. Goldberg J, Bryant M: Country ownership and capacity building: the next buzzwords in health systems strengthening or a truly new approach to development? / BMC public health 2012, 12:531. CrossRef
  10. LaFond AK, Brown L, Macintyre K: Mapping capacity in the health sector: a conceptual framework. / Int J Health Plann Manage 2002,17(1):3-2. CrossRef
  11. Cooke J: A framework to evaluate research capacity building in health care. / BMC Fam Pract 2005,6(44):1-1.
  12. Kula N, Fryatt RJ: Public-private interactions on health in South Africa: opportunities for scaling up. / Health Policy Plan 2013. doi:10.1093/heapol/czt042
  13. Wilkes L, Cummings J, McKay N: Developing a culture to facilitate research capacity building for clinical nurse consultants in generalist paediatric practice. / Nursing research and practice 2013, 2013:709025. CrossRef
  14. Sherraden MS, Stringham J, Sow SCS, McBride AM: The forms and structure of international voluntary service. / Volontas: Int J Volunt Nonprofit Organ 2006,17(2):156-73. CrossRef
  15. Lough BJ, Moore McBride A, Sherraden MS, O’Hara K: Capacity building contributions of short-term international volunteers. / J Community Pract 2011, 19:120-37. CrossRef
  16. Gilder D, Schuyt T, Breedijk M: Effects of an employee volunteering program on the work force: the ABN-AMRO case. / J Bus Ethics 2005,61(2):143-52. CrossRef
  17. Fink G, Meierewert S, Rohr U: The use of repatriate knowledge in organizations. / Hum Resour Plann 2005,28(4):30-6.
  18. Hawe P, Noort M, King L, Jordens C: Multiplying health gains: the critical role of capacity-building within health promotion programs. / Health Policy 1997,39(1):29-2. CrossRef
  19. Herman RD, Renz DO: Theses on nonprofit organizational effectiveness. / Nonprofit Volunt Sect Q 1999, 28:107-26. CrossRef
  20. MEASURE Evaluation: / Measuring Capacity Building in Health and Population Programs. Summary of a Meeting held by MEASURE Evaluation November 16-7, 1999. Arlington, VA: MEASURE Evaluation Project; 2000.
  21. Jones H: / A Guide to Monitoring and Evaluating Policy Influence. Background Note. UK: Overseas Development Institute; 2011:1-2.
  22. Feeley F, Connelly P, McCoy K, Richards S, Vian T: / Evaluation of the Pfizer Global Health Fellows Program. Boston, MA: Boston University Center for International Health and Development; 2006.
  23. Vian T, Richards S, Connelly P, McCoy K, Feeley F: Public-private partnerships to build capacity in low income countries: findings from the Pfizer program. / Hum Resour Health 2006.,5(8): doi:10.1186/1478-491--8 doi:10.1186/1478-4491-5-8
  24. Vian T, McCoy K, Richards SC, Connelly P, Feeley F: Corporate social responsibility in global health: the Pfizer Global Health Fellows international volunteering program. / Hum Resour Plan 2007,30(1):30-5.
  25. Vian T, Feeley F, MacLeod W, Richards S, McCoy K: / Measuring the impact of international corporate volunteering: lessons learned from the Global Health Fellows program of Pfizer Corporation. Boston, MA: Boston University School of Public Health; 2007.
  26. Johnson K, Hays C, Center H, Daley C: Building capacity and sustainable prevention innovations: a sustainability planning model. / Eval Program Plann 2004, 27:135-49. CrossRef
  27. Breitstein J, Spigelman M: The role of product development partnerships in advancing the development of drugs for unmet needs. / Clin Pharmacol Ther 2013,93(6):468-70. CrossRef
  28. Chataway J, Hanlin R: Sustainable (vaccine) Development: the International AIDS Vaccine Initiative (IAVI) and Capacity Building. In / Health Partnerships Review. Edited by: Matlin S, de Francisco A, Sundaram L, Faich H-S, Gehner M. Geneva: Global Forum for Health Research; 2008:43-5.
  29. Matlin S, de Francisco A, Sundaram L, Faich H-S, Gehner M: / Health Partnerships Review: Focusing Collaborative Efforts on Research and Innovation for the Health of the Poor. Geneva: Global Forum for Health Research; 2008.
  30. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/13/378/prepub
  
• 作者单位：Taryn Vian (4) (5)
  Sayaka Koseki (6)
  Frank G Feeley (4) (5)
  Jennifer Beard (4) (5)
  
  4. Center for Global Health and Development, Boston University, 801 Massachusetts Avenue, Boston, MA, 02118, USA
  5. Department of International Health, Boston University School of Public Health, 801 Massachusetts Avenue, Crosstown Building 3rd floor, Boston, MA, 02118, USA
  6. Abt Associates Inc, 4550 Montgomery Avenue, Suite 800N, Bethesda, MD, 20814, USA
  
• ISSN：1472-6963

文摘

Background Industry partnerships can help leverage resources to advance HIV/AIDS vaccine research, service delivery, and policy advocacy goals. This often involves capacity building for international and local non-governmental organizations (NGOs). International volunteering is increasingly being used as a capacity building strategy, yet little is known about how corporate volunteers help to improve performance of NGOs in the fight against HIV/AIDS. Methods This case study helps to extend our understanding by analyzing how the Pfizer Global Health Fellows (GHF) program helped develop capacity of the International AIDS Vaccine Initiative (IAVI), looking specifically at Fellowship activities in South Africa, Kenya, and Uganda. From 2005-009, 8 Pfizer GHF worked with IAVI and local research centers to strengthen capacity to conduct and monitor vaccine trials to meet international standards and expand trial activities. Data collection for the case study included review of Fellow job descriptions, online journals, evaluation reports, and interviews with Fellows and IAVI staff. Qualitative methods were used to analyze factors which influenced the process and outcomes of capacity strengthening. Results Fellows filled critical short-term expert staffing needs at IAVI as well as providing technical assistance and staff development activities. Capacity building included assistance in establishing operating procedures for the start-up period of research centers; training staff in Good Clinical Practice (GCP); developing monitoring capacity (staff and systems) to assure that centers are audit-ready at all times; and strategic planning for data management systems. Factors key to the success of volunteering partnerships included similarities in mission between the corporate and NGO partners, expertise and experience of Fellows, and attitudes of partner organization staff. Conclusion By developing standard operating procedures, ensuring that monitoring and regulatory compliance systems were in place, training African investigators and community members, and engaging in other systems strengthening activities, the GHF program helped IAVI to accelerate vaccine development activities in the field, and to develop the organization’s capacity to manage change in the future. Our study suggests that a program of sustained corporate volunteering over several years may increase organizational learning and trust, leading to stronger capacity to advance and achieve NGO goals.